Sintilimab
id:
sintilimab-252-9122400
title:
Sintilimab
text:
Sintilimab, sold under the brand Tyvyt among others, is a medication used to treat Hodgkin's disease, and has been approved in China. It is a fully human IgG4 monoclonal antibody that binds to programmed cell death protein 1. It was jointly developed by Innovent Biologics and Eli Lilly.
brand slug:
wiki
category slug:
encyclopedia
description:
Medication to treat Hodgkin's disease
original url:
https://en.wikipedia.org/wiki/Sintilimab
date created:
date modified:
2024-04-25T20:45:36Z
main entity:
{"identifier":"Q63313766","url":"https://www.wikidata.org/entity/Q63313766"}
image:
fields total:
13
integrity:
14